← Leaderboards
John Duffin Reveille
University Of Texas Hlth Sci Ctr Houston
$11,528,689
Attributed
$13,460,242
Total exposure
23
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$24,405,615 · 24
By mechanism
P01$15,539,136 · 10
R01$4,204,687 · 1
U01$2,897,329 · 1
T32$945,167 · 1
P50$551,163 · 1
M01$228,133 · 9
Top collaborators
- Maureen Maureen Mayes5 shared
- Xiaodong Zhou5 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Xiaodong Zhou$2,238,266
- Shervin Assassi$2,337,912
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchGeneticAnkylosing SpondylitisHuman SubjectGenome Wide Association StudyQuestionnairesGenesSpondylitisGenotypePredispositionHla-B27 AntigenPathogenesisDisease SusceptibilityBaseSeveritiesGenetic MarkersPhenotypeGenetic PolymorphismVariantFamily MemberRheumatoid ArthritisCohortGenetic AnalysisSampling
Grant awards (77)
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$981,731
P01 · FY2016 · AR · contact PI
Axial Spondyloarthritis (SpA)and HLA-B27 in First Degree Relatives of AS Patient$80,876
P01 · FY2016 · AR · contact PI
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$981,731
P01 · FY2015 · AR · contact PI
Axial Spondyloarthritis (SpA)and HLA-B27 in First Degree Relatives of AS Patient$80,876
P01 · FY2015 · AR · contact PI
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$830,788
P01 · FY2014 · AR · contact PI
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis$513,612
U01 · FY2014 · AI
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$122,661
P01 · FY2014 · AR · contact PI
Axial Spondyloarthritis (SpA)and HLA-B27 in First Degree Relatives of AS Patient$75,780
P01 · FY2014 · AR · contact PI
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$797,618
P01 · FY2013 · AR · contact PI
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis$492,173
U01 · FY2013 · AI
Axial Spondyloarthritis (SpA)and HLA-B27 in First Degree Relatives of AS Patient$63,458
P01 · FY2013 · AR · contact PI
Program Project Grant - Genetics and Ankylosing Spondylitis (AS) Pathogenesis$915,674
P01 · FY2012 · AR · contact PI
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis$761,277
U01 · FY2012 · AI
Axial Spondyloarthritis (SpA)and HLA-B27 in First Degree Relatives of AS Patient$76,395
P01 · FY2012 · AR · contact PI
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis$557,149
U01 · FY2011 · AI
Pre-and Postdoctoral Training in the Rheumatic Diseases$232,218
T32 · FY2011 · AR · contact PI
Genetics and Ankylosing Spondylitis (AS) Pathogenesis$675,821
P01 · FY2010 · AR · contact PI
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis$573,118
U01 · FY2010 · AI
Genotyping Core$386,877
P01 · FY2010 · AR · contact PI
Pre-and Postdoctoral Training in the Rheumatic Diseases$235,701
T32 · FY2010 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$84,131
P01 · FY2010 · AR · contact PI
Genetics and Ankylosing Spondylitis (AS) Pathogenesis$917,737
P01 · FY2009 · AR · contact PI
Genotyping Core$703,646
P01 · FY2009 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$63,281
P01 · FY2009 · AR · contact PI
Pre-and Postdoctoral Training in the Rheumatic Diseases$1,970
T32 · FY2009 · AR · contact PI
Genetics and Ankylosing Spondylitis (AS) Pathogenesis$1,660,755
P01 · FY2008 · AR · contact PI
Genotyping Core$986,035
P01 · FY2008 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$288,527
P01 · FY2008 · AR · contact PI
Pre-and Postdoctoral Training in the Rheumatic Diseases$237,639
T32 · FY2008 · AR · contact PI
Administrative/Sample and Data Management Core$211,650
P01 · FY2008 · AR · contact PI
Defining the Spectrum of Spondylitis in Family Members of Patients with AS$182,633
P01 · FY2008 · AR · contact PI
Genetic Basis of Ankylosing Spondylitis Susceptibility$101,297
P01 · FY2008 · AR · contact PI
Genetics and Ankylosing Spondylitis (AS) Pathogenesis$1,505,253
P01 · FY2007 · AR · contact PI
Pre-and Postdoctoral Training in the Rheumatic Diseases$237,639
T32 · FY2007 · AR · contact PI
Administrative/Sample and Data Management Core$224,985
P01 · FY2007 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$165,272
P01 · FY2007 · AR · contact PI
Defining the Spectrum of Spondyloarthritis in Family Members of Parents with ....$128,330
P01 · FY2007 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$98,497
P01 · FY2007 · AR · contact PI
Defining teh Spectrum of Spondyloarthritis in Family Members of Patients w/AS$81,164
P01 · FY2007 · AR · contact PI
The Genetic Basis of AS Susceptibility$70,771
P01 · FY2007 · AR · contact PI
Genetic Basis of Ankylosing Spondylitis Susceptibility$50,658
P01 · FY2007 · AR · contact PI
Genetics and Ankylosing Spondylitis (AS) Pathogenesis$1,555,604
P01 · FY2006 · AR · contact PI
Defining teh Spectrum of Spondyloarthritis in Family Members of Patients w/AS$166,686
P01 · FY2006 · AR · contact PI
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis$143,650
P01 · FY2006 · AR · contact PI
Genetic Basis of Ankylosing Spondylitis Susceptibility$78,288
P01 · FY2006 · AR · contact PI
Spondyloarthritis 2006; The Unmet Needs$40,000
R13 · FY2006 · AR · contact PI
OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS IN MINORITIES: NATURE VS NURTURE$56,213
M01 · FY2005 · RR
LONGITUDINAL STUDY OF GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY$45,402
M01 · FY2005 · RR
GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY$12,432
M01 · FY2005 · RR
FAMILY STUDIES OF MICROSATELLITE GENE MARKERS IN PATIENTS WITH AS$4,325
M01 · FY2005 · RR
Outcome of systemic lupus erythematosus in minorities$23,170
M01 · FY2004 · RR
Longitudinal study of genetic determinant of spondylitis$13,240
M01 · FY2004 · RR
Genetic determinants of ankylosing spondylitis severity$8,606
M01 · FY2004 · RR
Family studies of microsatellite gene markers in AS$8,275
M01 · FY2004 · RR
FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS$982,144
R01 · FY2003 · AR
FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS$963,658
R01 · FY2002 · AR
FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS$249,184
R01 · FY2002 · AR
Genetic vs environment in scleroderma outcomes study$183,721
P50 · FY2002 · AR
MYOPATHY IN HIV 1 INFECTION--PREVALENCE, IMMUNOGENETICS AND THERAPY$0
M01 · FY2002 · RR
Microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2002 · RR
DETERMINANTS OF OUTCOME IN SYSTEMIC SCLEROSIS (SSC)$0
M01 · FY2002 · RR
EPIDEMIOLOGY, GENETIC AND TREATMENT ISSUES IN DIFFUSE INFILTRATING LYMPHOCYTOSIS$0
M01 · FY2002 · RR
OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS IN MINORITIES--NATURE VS NURTURE$0
M01 · FY2002 · RR
FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS$984,253
R01 · FY2001 · AR
Genetic vs environment in scleroderma outcomes study$183,721
P50 · FY2001 · AR
OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS IN MINORITIES--NATURE VS NURTURE$0
M01 · FY2001 · RR
Microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2001 · RR
DETERMINANTS OF OUTCOME IN SYSTEMIC SCLEROSIS (SSC)$0
M01 · FY2001 · RR
EPIDEMIOLOGY, GENETIC AND TREATMENT ISSUES IN DIFFUSE INFILTRATING LYMPHOCYTOSIS$0
M01 · FY2001 · RR
MYOPATHY IN HIV 1 INFECTION--PREVALENCE, IMMUNOGENETICS AND THERAPY$0
M01 · FY2001 · RR
FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS$1,025,448
R01 · FY2000 · AR
IMPACT OF GENETIC, SOCIODEMOGRAPHIC AND BEHAVIORAL FACTORS ON SYSTEMIC SCLEROSIS$183,721
P50 · FY2000 · AR
OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS IN MINORITIES--NATURE VS NURTURE$15,114
M01 · FY2000 · RR
EPIDEMIOLOGY, GENETIC AND TREATMENT ISSUES IN DIFFUSE INFILTRATING LYMPHOCYTOSIS$15,114
M01 · FY2000 · RR
MYOPATHY IN HIV 1 INFECTION--PREVALENCE, IMMUNOGENETICS AND THERAPY$15,114
M01 · FY2000 · RR
DETERMINANTS OF OUTCOME IN SYSTEMIC SCLEROSIS (SSC)$11,128
M01 · FY2000 · RR
Microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2000 · RR